Cardiac Critical Care After Transcatheter Aortic Valve Replacement Matthew I. Tomey, MD, Umesh K. Gidwani, MD, Samin K. Sharma, MD Cardiology Clinics Volume 31, Issue 4, Pages 607-618 (November 2013) DOI: 10.1016/j.ccl.2013.07.006 Copyright © 2013 Elsevier Inc. Terms and Conditions
Fig. 1 Transcatheter valves currently in use in the United States. (A) Edwards SAPIEN valve (FDA approved). (B) Medtronic CoreValve (in phase 3 clinical trials). ([A] Courtesy of Edwards Lifesciences LLC, Irvine, CA; with permission. [B] Courtesy of Medtronic, Minneapolis, MN; with permission.) Cardiology Clinics 2013 31, 607-618DOI: (10.1016/j.ccl.2013.07.006) Copyright © 2013 Elsevier Inc. Terms and Conditions
Fig. 2 Post-TAVR care pathway. Cardiology Clinics 2013 31, 607-618DOI: (10.1016/j.ccl.2013.07.006) Copyright © 2013 Elsevier Inc. Terms and Conditions
Fig. 3 Approach to hypotension after TAVR. Cardiology Clinics 2013 31, 607-618DOI: (10.1016/j.ccl.2013.07.006) Copyright © 2013 Elsevier Inc. Terms and Conditions
Fig. 4 Approach to acute anemia after TAVR. Cardiology Clinics 2013 31, 607-618DOI: (10.1016/j.ccl.2013.07.006) Copyright © 2013 Elsevier Inc. Terms and Conditions